MICRON TECHNOLOGY INC financials

MU CIK 0000723125

Source: EDGAR filings · Built 2026-06-02T03:37:21Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.34B -34.00M -6.23B 3.01B 2.35B -165.00M
EBITDA 18.12B 9.08B 2.01B 16.82B 12.50B 8.65B
Working Capital 17.39B 15.12B 16.48B 14.24B 13.48B 11.33B
Net Debt 5.71B 7.04B 5.42B -686.00M -428.00M -394.00M
Gross Margin 39.79% 22.35% -9.11% 45.19% 37.62% 30.57%
Operating Margin 26.14% 5.19% -36.97% 31.54% 22.68% 14.01%
Net Margin 22.84% 3.10% -37.54% 28.24% 21.16% 12.54%
Return on Equity (ROE) 15.76% 1.72% -13.22% 17.41% 13.34% 6.89%
Return on Assets (ROA) 10.31% 1.12% -9.08% 13.11% 9.96% 5.01%
Current Ratio 2.52× 2.64× 4.46× 2.89× 3.10× 2.71×
Debt-to-Equity 0.28× 0.31× 0.32× 0.15× 0.17× 0.19×
Effective Tax Rate 11.64% 36.37% -3.13% 9.28% 6.34% 9.39%
Cash Conversion Ratio 2.05× 10.93× -0.27× 1.75× 2.13× 3.09×
Accruals Ratio -0.11× -0.11× -0.12× -0.10× -0.11× -0.10×
SBC % of Revenue 2.60% 3.32% 3.84% 1.67% 1.36% 1.53%
CapEx Coverage 1.08× 1.00× 0.20× 1.25× 1.23× 0.98×
Free Cash Flow Per Share $1.20 $-0.03 $-5.70 $2.68 $2.06 $-0.15

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 16.07× 136.53× 7.39× 14.39× 19.55×
P/FCF 102.04× 21.36× 35.88×
FCF Yield 0.98% 4.68% 2.79%
EV / EBITDA 7.87× 12.44× 40.88× 3.69× 6.59× 5.91×
P/S 3.66× 4.22× 4.94× 2.04× 2.99× 2.41×
P/B 2.53× 2.35× 1.74× 1.26× 1.88× 1.32×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 37.38B 25.11B 15.54B 30.76B 27.70B 21.43B
Cost of Goods and Services Sold 22.50B 19.50B 16.96B 16.86B 17.28B 14.88B
Gross Profit 14.87B 5.61B -1.42B 13.90B 10.42B 6.55B
Research and Development Expense 3.80B 3.43B 3.11B 3.12B 2.66B 2.60B
Selling, General and Administrative Expense 1.21B 1.13B 920.00M 1.07B 894.00M 881.00M
Operating Income (Loss) 9.77B 1.30B -5.75B 9.70B 6.28B 3.00B
Income Tax Expense (Benefit) 1.12B 451.00M 177.00M 888.00M 394.00M 280.00M
Net Income (Loss) Attributable to Parent 8.54B 778.00M -5.83B 8.69B 5.86B 2.69B
Earnings Per Share, Basic $7.65 $0.70 $-5.34 $7.81 $5.23 $2.42
Weighted Average Number of Shares Outstanding, Basic 1.12B 1.10B 1.09B 1.11B 1.12B 1.11B
Earnings Per Share, Diluted $7.59 $0.70 $-5.34 $7.75 $5.14 $2.37
Weighted Average Number of Shares Outstanding, Diluted 1.13B 1.12B 1.09B 1.12B 1.14B 1.13B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 9.64B 7.04B 8.58B 8.26B 7.76B 7.62B
Assets, Current 28.84B 24.37B 21.24B 21.78B 19.91B 17.96B
Assets 82.80B 69.42B 64.25B 66.28B 58.85B 53.68B
Long-term Debt 11.53B 11.34B 12.05B 6.02B 5.97B 6.16B
Liabilities, Current 11.45B 9.25B 4.76B 7.54B 6.42B 6.63B
Liabilities 28.63B 24.29B 20.13B 16.38B 14.92B 14.68B
Stockholders' Equity Attributable to Parent 54.16B 45.13B 44.12B 49.91B 43.93B 39.00B
Common Stock, Shares, Outstanding 1.12B 1.11B 1.10B 1.09B 1.12B 1.11B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 17.52B 8.51B 1.56B 15.18B 12.47B 8.31B
Payments to Acquire Property, Plant, and Equipment 15.86B 8.39B 7.68B 12.07B 10.03B 8.22B
Net Cash Provided by (Used in) Investing Activities -14.09B -8.31B -6.19B -11.59B -10.59B -7.59B
Payments for Repurchase of Common Stock 0 300.00M 425.00M 2.43B 1.20B 176.00M
Net Cash Provided by (Used in) Financing Activities -850.00M -1.84B 4.98B -2.98B -1.78B -317.00M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MU CIK 0000723125), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RCUS

Arcus Biosciences, Inc.

ASST

STRIVE, INC.

HCSG

HEALTHCARE SERVICES GROUP, INC.